**TP37** üáµüáπ

- A cadeia de transporte de eletr√µes
- Metabolismo Proteico e Ciclo da Ureia
- S√≠ntese e Degrada√ß√£o de √Åcidos Gordos
- Integra√ß√£o do Metabolismo

1\. O **Complexo I**, complexo NADH desidrogenase da cadeia respirat√≥ria mitocondrial, promove a seguinte s√©rie de **rea√ß√µes de oxida√ß√£o-redu√ß√£o**, em que **Fe¬≥‚Å∫** e **Fe¬≤‚Å∫** representam o ferro nos **centros ferro-enxofre**, **Q** √© **ubiquinona**, **QH‚ÇÇ** √© **ubiquinol** e **E** √© a enzima:

1. NADH + H<sup>+</sup> + E-FMN ‚Üí NAD<sup>+</sup> + E-FMNH<sub>2</sub>
2. E-FMNH<sub>2</sub> + 2Fe<sup>3+</sup> ‚Üí E-FMN + 2Fe<sup>2+</sup> + 2H<sup>+</sup>
3. 2Fe2<sup>+</sup> + 2H<sup>+</sup> + Q ‚Üí 2F2<sup>3+</sup> + QH<sub>2</sub>

_Soma:_ **NADH + H<sup>+</sup> + Q ‚Üí NAD<sup>+</sup> + QH<sub>2</sub>**

Para cada uma das tr√™s rea√ß√µes catalisadas pelo Complexo I, identifique:
**a)** o doador de eletr√µes
**b)** o aceitador de eletr√µes

**c)** o par redox conjugado
**d)** o agente redutor
**e)** o agente oxidante



**2.** Na transfer√™ncia de eletr√µes, apenas a por√ß√£o de **quinona** da **ubiquinona** sofre rea√ß√µes de **oxida√ß√£o-redu√ß√£o**; a cadeia lateral isoprenoide permanece inalterada.
**Qual √© a fun√ß√£o desta cadeia?**



**3.** Em mitoc√¥ndrias normais, a taxa de transfer√™ncia de eletr√µes est√° intimamente acoplada √†s necessidades de ATP. Quando a taxa de utiliza√ß√£o de ATP √© relativamente baixa, a taxa de transfer√™ncia de eletr√µes tamb√©m √© baixa; quando a necessidade por ATP aumenta, a taxa de transfer√™ncia de eletr√µes aumenta. Nessas condi√ß√µes de forte acoplamento, o n√∫mero de mol√©culas de ATP produzidas por √°tomo de oxig√©nio consumido, quando o **NADH √© o doador de eletr√µes** ‚Äî a raz√£o ATP/O<sub>2</sub> ‚Äî √© de cerca de 2,5.

**a.** Preveja o efeito de uma concentra√ß√£o relativamente baixa e de uma concentra√ß√£o relativamente alta de um **agente desacoplador** na taxa de transfer√™ncia de eletr√µes e na raz√£o ATP/O<sub>2</sub>.

**b.** A ingest√£o de desacopladores causa transpira√ß√£o intensa e um aumento na temperatura corporal. Explique este fen√≥meno em termos moleculares. O que acontece √† raz√£o ATP/O<sub>2</sub> na presen√ßa de desacopladores?

**c.** No passado, alguns m√©dicos prescreveram o desacoplador **2,4-dinitrofenol** (DNP) como um medicamento para reduzir peso. Como este agente poderia servir como um aux√≠lio na redu√ß√£o de peso? Atualmente, os m√©dicos j√° n√£o prescrevem agentes desacopladores devido a mortes associadas ao seu uso. Porque √© que a ingest√£o de desacopladores pode causar a morte?




**4.** O plasma sangu√≠neo humano normal cont√©m todos os amino√°cidos necess√°rios para a s√≠ntese de prote√≠nas do corpo, mas n√£o em concentra√ß√µes iguais. A **alanina** e a **glutamina** est√£o presentes em concentra√ß√µes muito mais elevadas do que qualquer outro amino√°cido. Porqu√™?




**5.** Se a sua dieta for rica em **alanina**, mas deficiente em aspartato, mostrar√° sinais de defici√™ncia de aspartato?




**6.** A aspartato aminotransferase tem a atividade mais elevada de todas as aminotransferases hep√°ticas nos mam√≠feros. Porqu√™?




**7.** Usando o seu conhecimento sobre a bioss√≠ntese de √°cidos gordos, forne√ßa uma explica√ß√£o para as duas observa√ß√µes experimentais:

**a.** Um bioqu√≠mico adiciona \[<sup>14</sup>C\]-acetil-CoA uniformemente marcado a uma fra√ß√£o hep√°tica sol√∫vel, que resulta em palmitato uniformemente marcado com <sup>14</sup>C.
b. Numa segunda experi√™ncia, o bioqu√≠mico adiciona uma quantidade residual de \[<sup>14</sup>C\]-acetil-CoA uniformemente marcado na presen√ßa de excesso de malonil-CoA n√£o marcado a uma fra√ß√£o hep√°tica sol√∫vel, que resulta em palmitato marcado com <sup>14</sup>C apenas em C-15 e C-16.

**8.** Ap√≥s a ingest√£o de grandes quantidades de sacarose, o corpo transforma a glucose e a frutose, que excedem os requisitos cal√≥ricos, em √°cidos gordos para a s√≠ntese de triacilglicer√≥is. Esta s√≠ntese de √°cidos gordos consome acetil-CoA, ATP e NADPH.
Como √© que as c√©lulas produzem acetil-CoA, ATP e NADPH a partir da glucose?

**9.** Por cada carbono, onde reside a maior quantidade de energia biologicamente dispon√≠vel nos triacilglicer√≥is: nas por√ß√µes de √°cidos gordos ou na por√ß√£o de glicerol? Indique como o conhecimento da estrutura qu√≠mica dos triacilglicer√≥is fornece a resposta.

**10.** A ativa√ß√£o do palmitato livre para o seu derivado coenzima A (palmitoil-CoA) no citosol ocorre antes de poder ser oxidado na mitoc√¥ndria. Ap√≥s adicionar palmitato e \[<sup>14</sup>C\]-coenzima A a um homogeneizado de f√≠gado, verifica-se que o palmitoil-CoA isolado da fra√ß√£o citos√≥lica √© radioativo, mas o isolado da fra√ß√£o mitocondrial n√£o o √©. Explique.




**11.** Que altera√ß√µes no padr√£o metab√≥lico resultariam de uma muta√ß√£o na carnitina aciltransferase 1 muscular, em que a prote√≠na mutante perdeu a afinidade pelo malonil-CoA, mas n√£o a sua atividade catal√≠tica?




**12.** Quantos ciclos de Œ≤-oxida√ß√£o s√£o necess√°rios para a oxida√ß√£o completa do √°cido oleico ativado, 18:1(Œî9)?



---


**TP37** üá¨üáß

- The electron transport chain
- Protein Metabolism and Urea Cycle
- Synthesis and breakdown of fatty acids
- Integration of Metabolism

**1.** Complex I, the NADH dehydrogenase complex of the mitochondrial respiratory chain, promotes the following
series of oxidation-reduction reactions, in which Fe<sup>3+</sup> and Fe<sup>2+</sup> represent the iron in
iron-sulfur centers, Q is ubiquinone, QH2 is ubiquinol, and E is the enzyme:

1\. NADH + H<sup>+</sup> + E-FMN ‚Üí NAD<sup>+</sup> + E-FMNH<sub>2</sub>

1. E-FMNH<sub>2</sub> + 2Fe<sup>3+</sup> ‚Üí E-FMN + 2Fe<sup>2+</sup> + 2H<sup>+</sup>
2. 2Fe2<sup>+</sup> + 2H<sup>+</sup> + Q ‚Üí 2F2<sup>3+</sup> + QH<sub>2</sub>

_Sum:_ **NADH + H<sup>+</sup> + Q ‚Üí NAD<sup>+</sup> + QH<sub>2</sub>**

For each of the three reactions catalyzed by Complex I, identify:

1. the electron donor
2. the electron acceptor
3. the conjugate redox pair
4. the reducing agen
5. the oxidizing agen




**2.** In electron transfer, only the **quinone** portion of **ubiquinone** undergoes **oxidation-reduction**; the isoprenoid
side chain remains unchanged.

**What is the function of this chain?**



**3.** In normal mitochondria, the rate of electron transfer is tightly coupled to the demand for ATP. When the rate of ATP use is relatively low, the rate of electron transfer is low; when demand for ATP increases, the electron-transfer rate increases. Under these conditions of tight coupling, the number of ATP molecules produced per atom of oxygen consumed when **NADH is the electron donor**, the ATP/O<sub>2</sub> ratio, is about 2.5.

**a.** Predict the effect of a relatively low and a relatively high concentration of uncoupling agent on the rate of electron transfer and the ATP/O<sub>2</sub> ratio.

**b.** Ingestion of uncouplers causes profuse sweating and an increase in body temperature. Explain this phenomenon in molecular terms. What happens to the ATP/O<sub>2</sub> ratio in the presence of uncouplers?

**c.** Physicians used to prescribe the uncoupler **2,4- dinitrophenol** (DNP) as a weight-reducing drug. How could this agent, in principle, serve as a weight reducing aid? Physicians no longer prescribe uncoupling agents, because some deaths occurred following their use. Why might the ingestion of uncouplers cause death?



**4.** Normal human blood plasma contains all the amino acids required for the synthesis of body proteins, but not in equal concentrations. **Alanine** and **glutamine** are present in much higher concentrations than any other amino acids. Why?



**5.** If your diet is rich in **alanine** but deficient in **aspartate**, will you show signs of **aspartate deficiency**?



**6.** **Aspartate aminotransferase** has the highest activity of all the mammalian liver aminotransferases. Why?



**7.** Using your knowledge of **fatty acid biosynthesis**, provide an explanation for the two experimental observations.

**a.** A biochemist adds uniformly labeled \[<sup>14</sup>C\]-acetyl-CoA to a soluble liver fraction, which yields palmitate uniformly labeled with <sup>14</sup>C.

**b.** In a second experiment, the biochemist adds a trace of uniformly labeled \[<sup>14</sup>C\] acetyl-CoA in the presence of an excess of unlabeled malonyl-CoA to a soluble liver

fraction, which yields palmitate labeled with <sup>14</sup>C only in C-15 and C-16.



**8.** After a person has ingested large amounts of **sucrose**, the body transforms the **glucose** and **fructose** that exceed caloric requirements to fatty acids for triacylglycerol synthesis. This fatty acid synthesis consumes acetyl-CoA, ATP, and NADPH.

**How do cells produce acetyl-CoA, ATP, and NADPH from glucose?**



**9.** On a per-carbon basis, where does the largest amount of biologically available energy in triacylglycerols reside: in the **fatty acid portions** or in the **glycerol portion**? Indicate how knowledge of the chemical structure of triacylglycerols provides the answer.



**10.** The activation of free palmitate to its coenzyme A derivative (palmitoyl-CoA) in the cytosol occurs before it can be oxidized in the mitochondrion. After adding palmitate and \[<sup>14</sup>C\]coenzyme A to a liver homogenate, you find palmitoyl-CoA isolated from the cytosolic fraction is radioactive, but that isolated from the mitochondrial fraction is not. Explain.



**11.** What changes in metabolic pattern would result from a mutation in the muscle carnitine acyltransferase 1 in which the mutant protein has lost its affinity for malonyl-CoA but not its catalytic activity?



**12.** How many cycles of Œ≤-oxidation are required for the complete oxidation of activated oleic acid, 18:1(Œî9)?


















<!--


#  Metabolism II

- The electron transport chain
- Protein Metabolism and Urea Cycle
- Synthesis and Breakdown of Fatty Acids
- Integration of Metabolism

## Question 1

Using the axes from the illustration, plot the oxygen uptake in a mitochondrial suspension as the following elements are added in the specified order.
At time 0, assume the level oxygen consumption indicated by the horizontal line, and note that oxygen consumption can only increase or remain constant.


![[TPs/TP36 Metabolism/TP36 Metabolism-20241016115538501.png]]

| Component     | Time point |
| ------------- | ---------- |
| Glucose       | a          |
| ADP¬†+¬†Pi      | b          |
| Citrato       | c          |
| Oligomycin    | d          |
| Succinate     | e          |
| Dinitrophenol | f          |
| Rotenone      | g          |
| Cyanide       | h          |

![[TPs/TP36 Metabolism/TP36 Metabolism-20241016114733194.png]]
`8.fosforila√ß√£o oxidativa4.pdf`


## Question 2

This question involves calculating the Gibbs free energy change for the Citrate Synthase Reaction. The first step of the Krebs cycle involves the condensation of acetyl-CoA and oxaloacetate to form citrate, catalyzed by the enzyme citrate synthase. Calculate the Gibbs free energy change (ŒîG) for this reaction a
standard conditions (T = 298 K, P = 1 atm) given the following standard Gibbs free energy of formation values:

ŒîG¬∞f (acetyl-CoA) = -31.5 kJ/mol
ŒîG¬∞f (oxaloacetate) = -379.8 kJ/mol
ŒîG¬∞f (citrate) = -380.3 kJ/mol


## Question 3
This question involves determining the equilibrium constant for the Isocitrate Dehydrogenase Reaction. The isocitrate dehydrogenase enzyme catalyzes the conversion of isocitrate to Œ±-ketoglutarate in the Krebs cycle. Calculate the equilibrium constant (K) for this reaction at 25¬∞C (298 K) using the standard
Gibbs free energy change (ŒîG¬∞) value of -8.4 kJ/mol.

## Question 4
Calculating the Standard Enthalpy Change for the Malate Dehydrogenase Reaction

The conversion of malate to oxaloacetate by malate dehydrogenase is an important step in the Krebs cycle.
Calculate the standard enthalpy change (ŒîH¬∞) for this reaction using the following information:

ŒîG¬∞ = -29.7 kJ/mol
ŒîS¬∞ = -112.1 J/(mol¬∑K)
## Question 5

TBD

--!>
